2025年全球乾粉吸入器市場報告

預計未來幾年乾粉吸入器的市場規模將穩定成長。到 2029 年，這一數字將成長至 271.3 億美元，複合年成長率為 5.0%。預測期內的成長可歸因於對永續性、全球都市化趨勢、製造流程的進步、政府激勵和政策以及全球經濟因素的持續關注。預測期內的關鍵趨勢包括研究和開發的增加、對傳統建築技術的重新興趣、材料技術的進步、建築和設計趨勢以及對永續建築的監管支持。

預計呼吸系統疾病的日益普及將在未來幾年推動乾粉吸入器市場的成長。呼吸系統疾病涵蓋影響呼吸系統的多種疾病，包括各種肺部疾病。乾粉吸入器透過將藥物直接輸送到最有效的肺部，在治療氣喘、慢性阻塞性肺病和囊腫纖維化等呼吸系統疾病方面發揮著至關重要的作用。該方法代表了治療呼吸系統疾病的傳統藥物傳輸技術的一種有前途的替代方法。例如，根據美國醫學會醫學雜誌《JAMA Network Open》2023年12月發表的一項研究，預計到2050年，全球慢性阻塞性肺病（COPD）負擔將達到近6億例，患病率將增加23%。值得注意的是，女性病例預計將增加 47.1%，而男性病例預計僅增加 9.4%。此外，大多數病例發生在中低收入地區，預計到 2050 年這些地區的發病率將是高所得地區的兩倍多。因此，呼吸系統疾病盛行率的上升將大大促進乾粉吸入器市場的擴張。

此外，空氣污染程度的加劇也有望促進乾粉吸入器市場的成長。空氣污染（以空氣中各種污染物的濃度來衡量）會導致呼吸問題，因此乾粉吸入器是緩解空氣污染物加劇的症狀和控制呼吸系統疾病的首選藥物輸送方法。 2022年，美國環保署報告稱，美國排放到空氣中的污染物數量約為6,600萬噸。此外，2023 年 3 月，IQAir 報告稱，伊拉克是 2022 年污染第二嚴重的國家，PM2.5 濃度為 80.1μg/m3，是世衛組織年度 PM2.5 指導值的 16 倍。因此，預計空氣污染水平的上升將推動乾粉吸入器市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 世界乾粉吸入器PESTEL分析（政治、社會、科技、環境、法律因素、促進因素、限制因素）
• 最終用途產業分析
• 全球乾粉吸入器市場：成長率分析
• 全球乾粉吸入器市場表現：規模與成長，2019-2024
• 全球乾粉吸入器市場預測：規模與成長，2024-2029 年，2034 年
• 全球乾粉吸入器總目標市場（TAM）

第6章市場區隔

• 全球乾粉吸入器市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 單劑量吸入器
• 多劑量吸入器
• 全球乾粉吸入器市場：按功能、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 手動復甦器
• 數位操作吸入器
• 全球乾粉吸入器市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 氣喘
• 慢性阻塞性肺病（COPD）
• 囊腫纖維化
• 其他用途
• 全球乾粉吸入器市場：依最終用戶、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 醫院和診所
• 家庭護理設置
• 門診手術中心
• 其他最終用戶
• 全球乾粉吸入器市場，按單劑量吸入器類型細分，性能和預測，2019-2024 年、2024-2029 年、2034 年
• 膠囊吸入器
• 乾粉吸入器
• 全球乾粉吸入器市場，按多劑量吸入器類型細分，性能和預測，2019-2024 年、2024-2029 年、2034 年
• 泡殼式吸入器
• Rotaheler 吸入器

第7章 區域和國家分析

• 全球乾粉吸入器市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球乾粉吸入器市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

• 乾粉吸入器市場：競爭格局
• 乾粉吸入器市場：公司簡介
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
  • 3M Company Overview, Products and Services, Strategy and Financial Analysis
  • Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• Viatris（Mylan NV）
• Otsuka Pharmaceutical Co. Ltd
• Sun Pharmaceutical Industries Limited
• Catalent Inc.
• Aptar Group Inc.
• Chiesi Farmaceutici SpA
• Recipharm AB
• Cipla Limited
• Lupin Limited
• Orion Corporation
• OPKO Health
• Zhejiang Hisun Pharmaceutical Co Ltd
• Beximco Pharmaceuticals Ltd
• Sava Healthcare Ltd.
• Hovione

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029年乾粉吸入器市場：提供新機會的國家
• 2029年乾粉吸入器市場：細分市場帶來新機會
• 2029年乾粉吸入器市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第36章 附錄

A dry powder inhaler (DPI) is a medical device designed for delivering medication in the form of dry powder directly to the lungs. It is primarily used for treating respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). To effectively use a DPI, it is crucial for the user to inhale rapidly and deeply, allowing the medication to reach the lungs.

The main types of dry powder inhalers include single-dose inhalers and multi-dose inhalers. Single-dose inhalers are devices that administer medication directly to the lungs in the form of dry powder. These devices can be either manually operated or digitally operated, and they find applications in treating conditions such as asthma, COPD, cystic fibrosis, and others. Various end-users, including hospitals and clinics, homecare settings, and ambulatory surgical centers, utilize these inhalers.

The dry powder inhaler market research report is one of a series of new reports from The Business Research Company that provides dry powder inhaler market statistics, including dry powder inhaler industry global market size, regional shares, competitors with a dry powder inhaler market share, detailed dry powder inhaler market segments, market trends and opportunities, and any further data you may need to thrive in the dry powder inhaler industry. This dry powder inhaler market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dry powder inhaler market size has grown strongly in recent years. It will grow from $21.25 billion in 2024 to $22.35 billion in 2025 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to renewed interest in sustainable building materials, cultural preservation and heritage restoration, rise in green building practices, local sourcing and community involvement, regulatory support and building codes.

The dry powder inhaler market size is expected to see steady growth in the next few years. It will grow to $27.13 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to continued emphasis on sustainability, global urbanization trends, advancements in manufacturing processes, government incentives and policies, global economic factors. Major trends in the forecast period include increased research and development, renewed interest in traditional building techniques, advancements in material technology, architectural and design trends, regulatory support for sustainable construction.

The increasing prevalence of respiratory diseases is anticipated to boost the growth of the dry powder inhaler market in the future. Respiratory diseases encompass a wide range of disorders affecting the respiratory system, including various lung diseases. Dry powder inhalers play a critical role in treating respiratory conditions such as asthma, COPD, and cystic fibrosis by delivering medication directly to the lungs, where it is most effective. This method serves as a promising alternative to traditional drug delivery techniques for respiratory issues. For example, a study published in December 2023 by JAMA Network Open, a medical journal of the American Medical Association, indicates that the global burden of chronic obstructive pulmonary disease (COPD) is projected to nearly reach 600 million cases worldwide by 2050, reflecting a 23% increase in prevalence. Notably, cases among females are expected to surge by 47.1%, while male cases are projected to rise by only 9.4%. Additionally, the majority of these cases are expected to occur in low- and middle-income regions, where the prevalence is anticipated to be more than double that of high-income areas by 2050. Consequently, the growing prevalence of respiratory diseases will significantly drive the expansion of the dry powder inhaler market.

The increasing levels of air pollution are also anticipated to contribute to the growth of the dry powder inhaler market. Air pollution, measured by the concentration of various pollutants in the atmosphere, leads to respiratory issues, making dry powder inhalers a preferred delivery method for medications that alleviate symptoms and manage respiratory conditions exacerbated by airborne pollutants. In 2022, the United States Environmental Protection Agency reported approximately 66 million tons of pollutants released into the atmosphere in the United States. Additionally, in March 2023, IQAir reported that Iraq was the second most polluted country with 80.1 µg/m3, 16 times higher than the WHO PM2.5 annual guideline in 2022. Therefore, the rising levels of air pollution are expected to drive the growth of the dry powder inhaler market.

Key players in the dry powder inhaler market are focusing on developing innovative products featuring muscarinic antagonists for the treatment of chronic obstructive pulmonary disease (COPD) while also expanding their product portfolios. Muscarinic antagonists are drugs that inhibit the muscarinic acetylcholine receptor, and they are used to manage various conditions, including COPD and organophosphate poisoning. For example, in March 2024, Berry Global, a US-based company recognized for its development and manufacturing of diverse flexible packaging solutions, unveiled its new dry powder inhaler at Pharma Pack. This inhaler is specifically designed to improve drug delivery for respiratory conditions such as COPD and asthma, providing a customizable solution for pharmaceutical companies.

In August 2024, Aptar Pharma, a US-based specialist in drug delivery, acquired the Orbital Dry Powder Inhaler for an undisclosed sum. This acquisition strengthens Aptar's capabilities in respiratory drug delivery, especially for managing conditions such as asthma and chronic obstructive pulmonary disease (COPD). The Orbital Dry Powder Inhaler is noted for its innovative design, which enhances medication delivery. This acquisition aligns with Aptar Pharma's strategy to expand its product offerings and reinforce its position in the respiratory treatment market. The Orbital DPI operates within the pharmaceutical and medical device sectors in India.

Major companies operating in the dry powder inhaler market report are Novartis AG, AstraZeneca plc., GlaxoSmithKline PLC, 3M Company, Boehringer Ingelheim GmbH, Viatris (Mylan N.V), Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Catalent Inc., Aptar Group Inc., Chiesi Farmaceutici S.p.A., Recipharm AB, Cipla Limited, Lupin Limited, Orion Corporation, OPKO Health, Zhejiang Hisun Pharmaceutical Co Ltd., Beximco Pharmaceuticals Ltd., Sava Healthcare Ltd., Hovione, Elpen S.A., MannKind Corporation, Meda Pharmaceuticals, Presspart Manufacturing Ltd., SMB Laboratories SA, Teva Pharmaceutical Industries Limited, Pharmaxis Ltd., Iconovo AB, SRS Pharmaceuticals Pvt. Ltd.

North America was the largest region in the dry powder inhaler market in 2024. The regions covered in the dry powder inhaler market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the Dry Powder Inhaler market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dry powder inhaler market consists of sales of dry powder forms, spiriva handihalers, breath-activated inhalers, rotahalers, diskus devices, and twisthaler inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dry Powder Inhaler Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dry powder inhaler market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dry powder inhaler ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dry powder inhaler market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Single-Dose Inhalers; Multi-Dose Inhalers
• 2) By Function: Manually Operated Inhaler Devices; Digitally Operated Inhaler Devices
• 3) By Application: Asthma; Chronic Obstructive Pulmonary Disease (COPD); Cystic Fibrosis; Other Applications
• 4) By End User: Hospitals And Clinics; Homecare Settings; Ambulatory Surgical Centers; Other End Users
• Subsegments:
• 1) By Single-Dose Inhalers: Capsule-Based Inhalers; Diskus-Based Inhalers
• 2) By Multi-Dose Inhalers: Blister-Based Inhalers; Rotahaler-Based Inhalers
• Companies Mentioned: Novartis AG; AstraZeneca plc.; GlaxoSmithKline Plc; 3M Company; Boehringer Ingelheim GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Dry Powder Inhaler Market Characteristics

3. Dry Powder Inhaler Market Trends And Strategies

4. Dry Powder Inhaler Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Dry Powder Inhaler Growth Analysis And Strategic Analysis Framework

• 5.1. Global Dry Powder Inhaler PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Dry Powder Inhaler Market Growth Rate Analysis
• 5.4. Global Dry Powder Inhaler Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Dry Powder Inhaler Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Dry Powder Inhaler Total Addressable Market (TAM)

6. Dry Powder Inhaler Market Segmentation

• 6.1. Global Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Dose Inhalers
• Multi-Dose Inhalers
• 6.2. Global Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Manually Operated Inhaler Devices
• Digitally Operated Inhaler Devices
• 6.3. Global Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Cystic Fibrosis
• Other Applications
• 6.4. Global Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Homecare Settings
• Ambulatory Surgical Centers
• Other End Users
• 6.5. Global Dry Powder Inhaler Market, Sub-Segmentation Of Single-Dose Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Capsule-Based Inhalers
• Diskus-Based Inhalers
• 6.6. Global Dry Powder Inhaler Market, Sub-Segmentation Of Multi-Dose Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blister-Based Inhalers
• Rotahaler-Based Inhalers

7. Dry Powder Inhaler Market Regional And Country Analysis

• 7.1. Global Dry Powder Inhaler Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Dry Powder Inhaler Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Dry Powder Inhaler Market

• 8.1. Asia-Pacific Dry Powder Inhaler Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Dry Powder Inhaler Market

• 9.1. China Dry Powder Inhaler Market Overview
• 9.2. China Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Dry Powder Inhaler Market

• 10.1. India Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Dry Powder Inhaler Market

• 11.1. Japan Dry Powder Inhaler Market Overview
• 11.2. Japan Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Dry Powder Inhaler Market

• 12.1. Australia Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Dry Powder Inhaler Market

• 13.1. Indonesia Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Dry Powder Inhaler Market

• 14.1. South Korea Dry Powder Inhaler Market Overview
• 14.2. South Korea Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Dry Powder Inhaler Market

• 15.1. Western Europe Dry Powder Inhaler Market Overview
• 15.2. Western Europe Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Dry Powder Inhaler Market

• 16.1. UK Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Dry Powder Inhaler Market

• 17.1. Germany Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Dry Powder Inhaler Market

• 18.1. France Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Dry Powder Inhaler Market

• 19.1. Italy Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Dry Powder Inhaler Market

• 20.1. Spain Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Dry Powder Inhaler Market

• 21.1. Eastern Europe Dry Powder Inhaler Market Overview
• 21.2. Eastern Europe Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Dry Powder Inhaler Market

• 22.1. Russia Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Dry Powder Inhaler Market

• 23.1. North America Dry Powder Inhaler Market Overview
• 23.2. North America Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Dry Powder Inhaler Market

• 24.1. USA Dry Powder Inhaler Market Overview
• 24.2. USA Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Dry Powder Inhaler Market

• 25.1. Canada Dry Powder Inhaler Market Overview
• 25.2. Canada Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Dry Powder Inhaler Market

• 26.1. South America Dry Powder Inhaler Market Overview
• 26.2. South America Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Dry Powder Inhaler Market

• 27.1. Brazil Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Dry Powder Inhaler Market

• 28.1. Middle East Dry Powder Inhaler Market Overview
• 28.2. Middle East Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Dry Powder Inhaler Market

• 29.1. Africa Dry Powder Inhaler Market Overview
• 29.2. Africa Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Dry Powder Inhaler Market Competitive Landscape And Company Profiles

• 30.1. Dry Powder Inhaler Market Competitive Landscape
• 30.2. Dry Powder Inhaler Market Company Profiles
  • 30.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. 3M Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Dry Powder Inhaler Market Other Major And Innovative Companies

• 31.1. Viatris (Mylan N.V)
• 31.2. Otsuka Pharmaceutical Co. Ltd
• 31.3. Sun Pharmaceutical Industries Limited
• 31.4. Catalent Inc.
• 31.5. Aptar Group Inc.
• 31.6. Chiesi Farmaceutici S.p.A.
• 31.7. Recipharm AB
• 31.8. Cipla Limited
• 31.9. Lupin Limited
• 31.10. Orion Corporation
• 31.11. OPKO Health
• 31.12. Zhejiang Hisun Pharmaceutical Co Ltd
• 31.13. Beximco Pharmaceuticals Ltd
• 31.14. Sava Healthcare Ltd.
• 31.15. Hovione

32. Global Dry Powder Inhaler Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Dry Powder Inhaler Market

34. Recent Developments In The Dry Powder Inhaler Market

35. Dry Powder Inhaler Market High Potential Countries, Segments and Strategies

• 35.1 Dry Powder Inhaler Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Dry Powder Inhaler Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Dry Powder Inhaler Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer